Source: Pharamceutical Technology

Navidea: Navidea Biopharmaceuticals gets grant for method for conjugating metal chelating agent to functionalized dextran

Discover Navidea Biopharmaceuticals Inc's innovative method for conjugating metal chelating agents to dextran, free of crosslinking. Explore potential applications in medical imaging and drug delivery with this groundbreaking patent.

Read full article »
Annual Revenue
$100K-5.0M
Employees
1-25
CEO Avatar

CEO

- -

CEO Approval Rating

- -/100

Read more